[go: up one dir, main page]

FI20065514A0 - Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi - Google Patents

Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi

Info

Publication number
FI20065514A0
FI20065514A0 FI20065514A FI20065514A FI20065514A0 FI 20065514 A0 FI20065514 A0 FI 20065514A0 FI 20065514 A FI20065514 A FI 20065514A FI 20065514 A FI20065514 A FI 20065514A FI 20065514 A0 FI20065514 A0 FI 20065514A0
Authority
FI
Finland
Prior art keywords
treatment
tissue damage
activated fibroblasts
fibroblasts
activated
Prior art date
Application number
FI20065514A
Other languages
English (en)
Swedish (sv)
Inventor
Jozef Bizik
Ari Harjula
Esko Kankuri
Antti Vaheri
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Priority to FI20065514A priority Critical patent/FI20065514A0/fi
Publication of FI20065514A0 publication Critical patent/FI20065514A0/fi
Priority to US12/377,585 priority patent/US20110123572A1/en
Priority to EP07803711A priority patent/EP2046948A4/en
Priority to PCT/FI2007/050448 priority patent/WO2008020119A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20065514A 2006-08-16 2006-08-16 Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi FI20065514A0 (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20065514A FI20065514A0 (fi) 2006-08-16 2006-08-16 Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi
US12/377,585 US20110123572A1 (en) 2006-08-16 2007-08-16 Activated fibroblasts for treating tissue and/or organ damage
EP07803711A EP2046948A4 (en) 2006-08-16 2007-08-16 ACTIVATED FIBROBLASTES FOR THE TREATMENT OF TISSUE AND / OR ORGANIC DAMAGE
PCT/FI2007/050448 WO2008020119A1 (en) 2006-08-16 2007-08-16 Activated fibroblasts for treating tissue and/or organ damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20065514A FI20065514A0 (fi) 2006-08-16 2006-08-16 Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi

Publications (1)

Publication Number Publication Date
FI20065514A0 true FI20065514A0 (fi) 2006-08-16

Family

ID=36950693

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20065514A FI20065514A0 (fi) 2006-08-16 2006-08-16 Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi

Country Status (4)

Country Link
US (1) US20110123572A1 (fi)
EP (1) EP2046948A4 (fi)
FI (1) FI20065514A0 (fi)
WO (1) WO2008020119A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095355A0 (fi) * 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
KR101811912B1 (ko) 2011-03-04 2017-12-22 아메드 에이치. 알-칸타니 스킨 크림
AU2018207541B2 (en) * 2017-01-11 2023-12-21 Spinalcyte, Llc Methods of enhancing fibroblast therapeutic activity
EP3716988A4 (en) 2017-11-29 2021-12-15 Figene, LLC INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND THEIR USES
CN112280731B (zh) * 2020-09-30 2022-07-22 华东交通大学 一种诱导脂肪干细胞定向分化为人皮肤成纤维细胞的方法及用途
CA3252935A1 (en) * 2022-03-16 2023-09-21 Fibrobiologics, Inc. THERAPEUTIC USE OF FIBROBLASTS INTENDED FOR USE IN WOUND HEALING

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9003621D0 (en) * 1990-02-16 1990-04-11 Imp Cancer Res Tech Protein factor
WO1999048537A1 (en) * 1998-03-26 1999-09-30 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
FR2807765B1 (fr) * 2000-04-18 2004-12-31 Cell Culture Ct Comp Procede de culture de cellules, amas cellulaires obtenus par ces procedes et utilisation de ceux-ci

Also Published As

Publication number Publication date
EP2046948A1 (en) 2009-04-15
EP2046948A4 (en) 2010-11-03
US20110123572A1 (en) 2011-05-26
WO2008020119A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
EP1981457A4 (en) SURGICAL WONDERFLY
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
IL198663A0 (en) Tissue treatment methods
DE602007011342D1 (de) Endoskop-Behandlungswerkzeug
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
EP2121110A4 (en) BIOKOMPATIBLE WUNDAUFLAGE
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
EP2049713A4 (en) tissue rejection
EP1908389A4 (en) MEDICAL CONTROLLER
DE602007006594D1 (de) Endoskop-Behandlungsinstrument
EP2046315A4 (en) THERAPEUTIC AGENTS FOR THE TREATMENT OF LYMPHOID MALIGNANCIES
DK3150209T3 (da) Okulære allergibehandlinger
DE602008004368D1 (de) Endoskop-Behandlungswerkzeug
DK2035369T3 (da) Terapeutiske
EP2051651A4 (en) LASER TREATMENT OF TISSUE
DK1993589T3 (da) Behandlinger for neurologiske sygdomme
DK2173831T3 (da) Brøndbehandling
EP1984017A4 (en) PROCEDURE FOR THE THERAPY OR PROPHYLAXIS OF TISSUE DAMAGE CAUSED BY INCREASED BLEACHING
DK1863899T3 (da) Hudbehandlingspræparater
DE602008000310D1 (de) Endoskopisches Behandlungswerkzeug
EP2091480A4 (en) SYSTEM FOR THE TREATMENT OF HEART TISSUE
WO2008002855A8 (en) Methods for the treatment of wounds
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
ITRE20060127A1 (it) Apparecchio per trattamenti medicali
DE602008006133D1 (de) Endoskopisches Behandlungswerkzeug

Legal Events

Date Code Title Description
FD Application lapsed